1 Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. The Lancet. 2005 Jul;366:144-50.
2 Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003 May;348(18):1737-46.
3 Sahakyan G, Grigoryan S, Wasley A, Mosina L, Sargsyan S et al. Impact and effectiveness of monovalent rotavirus vaccine in Armenian children. Clinical Infectious Diseases. 2016 May. 62(S2): 147-54.
4 Gheorgita S, Birca L, Donos A, Wasley A, Birca I et al. Impact of Rotavirus introduction and vaccine effectiveness in the Republic of Moldova. Clinical Infectious Diseases. 2016 May. 62(S2): 140-6.
5 Chang HG, Smith PF, Tserenpuntsag B, Markey K, Parashar U, Morse DL. Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine. Vaccine. 2010 Jan;28(3):754-8
6 Neill, J (Chair). Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance. 2016 May.
7 Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A et al. Prevention of antibiotic non susceptible Streptococcus pneumoniae with conjugate vaccines. Journal of Infectious Diseases. 2012 Feb;203(3):401-11.
8 Laxminarayan R, Matsoso P, Pant S, Brower C, Rottingen J.A. et al. Access to effective antimicrobials: a worldwide challenge. The Lancet. 2016 Jun;387(10036):168-75